WWH vs. SDR, ICP, SDRC, FCIT, HL, MNG, PCT, ATST, UKW, and 3IN
Should you be buying Worldwide Healthcare stock or one of its competitors? The main competitors of Worldwide Healthcare include Schroders (SDR), Intermediate Capital Group (ICP), Schroders (SDRC), F&C Investment Trust (FCIT), Hargreaves Lansdown (HL), M&G (MNG), Polar Capital Technology Trust (PCT), Alliance Trust (ATST), Greencoat UK Wind (UKW), and 3i Infrastructure (3IN). These companies are all part of the "asset management" industry.
Worldwide Healthcare (LON:WWH) and Schroders (LON:SDR) are both financial services companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, community ranking, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment.
In the previous week, Worldwide Healthcare had 7 more articles in the media than Schroders. MarketBeat recorded 7 mentions for Worldwide Healthcare and 0 mentions for Schroders. Worldwide Healthcare's average media sentiment score of 0.08 beat Schroders' score of 0.00 indicating that Worldwide Healthcare is being referred to more favorably in the media.
Schroders has a net margin of 13.48% compared to Worldwide Healthcare's net margin of 0.00%. Schroders' return on equity of 9.00% beat Worldwide Healthcare's return on equity.
Schroders has higher revenue and earnings than Worldwide Healthcare. Worldwide Healthcare is trading at a lower price-to-earnings ratio than Schroders, indicating that it is currently the more affordable of the two stocks.
Worldwide Healthcare pays an annual dividend of GBX 3 per share and has a dividend yield of 0.9%. Schroders pays an annual dividend of GBX 22 per share and has a dividend yield of 5.6%. Worldwide Healthcare pays out -2,000.0% of its earnings in the form of a dividend. Schroders pays out 9,166.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Schroders has a consensus target price of GBX 432, suggesting a potential upside of 10.26%. Given Schroders' higher probable upside, analysts clearly believe Schroders is more favorable than Worldwide Healthcare.
Worldwide Healthcare has a beta of 0.29, suggesting that its share price is 71% less volatile than the S&P 500. Comparatively, Schroders has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500.
73.6% of Worldwide Healthcare shares are owned by institutional investors. Comparatively, 36.5% of Schroders shares are owned by institutional investors. 0.4% of Worldwide Healthcare shares are owned by insiders. Comparatively, 43.1% of Schroders shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Schroders received 401 more outperform votes than Worldwide Healthcare when rated by MarketBeat users. However, 67.29% of users gave Worldwide Healthcare an outperform vote while only 60.25% of users gave Schroders an outperform vote.
Summary
Schroders beats Worldwide Healthcare on 14 of the 19 factors compared between the two stocks.
Get Worldwide Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for WWH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding WWH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Worldwide Healthcare Competitors List
Related Companies and Tools
